Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRCL-02 in Normal Healthy Volunteers and Chronic Plaque Psoriasis Patients
NCT03062618Phase 1Completed
- Sponsor
- PRCL Research
- Start
- Feb 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of PRCL-02 in plaque psoriasis (6 arms), sponsored by PRCL Research. Primary endpoint: Number of Participants with One or More Serious Adverse Events at 73 days. Started Feb 2017; status: completed.
02
Drugs
PRCL-02
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03062618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062618.